336
Views
38
CrossRef citations to date
0
Altmetric
Psoriasis

Concurrent use of methotrexate and acitretin revisited

, &
Pages 22-26 | Received 24 Sep 2007, Accepted 29 Sep 2007, Published online: 12 Jul 2009

References

  • Acitretin [package insert]. Connetics Corporation, Palo Alto, CA 2004
  • Gronhoj Larsen F., Steinkjer B., Jakobsen P., Hjorter A., Brockhoff P. B., Nielsen‐Kudsk F. Acitretin is converted to etretinate only during concomitant alcohol intake. Br J Dermatol 2000; 143: 1164–9
  • Hu J., Balkrishnan R., Camacho F., et al. The frequent use of oral retinoids in combination with other treatments for psoriasis: A retrospective analysis. J Cutan Med Surg 2004; 8: 411–14
  • National Psoriasis Foundation, About psoriasis: FAQs. Accessed Dec 1 2005. URL: http://www.psoriasis.org/about/faq.
  • Rosenbaum M. M., Roenigk H. H., Jr. Treatment of generalized pustular psoriasis with etretinate (Ro 10‐9359) and methotrexate. J Am Acad Dermatol 1984; 10: 357–61
  • Vanderveen E. E., Ellis C. N., Campbell J. P., Case P. C., Voorhees J. J. Methotrexate and etretinate as concurrent therapies in severe psoriasis. Arch Dermatol 1982; 118: 660–2
  • Pearce D. J., Klinger S., Ziel K. K., Murad E. J., Rowell R., Feldman S. R. Low‐dose acitretin is associated with fewer adverse events than high‐dose acitretin in the treatment of psoriasis. Arch Dermatol 2006; 142: 1000–4
  • Weinstein G., Roenigk H., Maibach H., et al. Psoriasis‐liver methotrexate interactions. Arch Dermatol 1973; 108: 36–42
  • Nyfors A. Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Scand 1977; 85: 511–518
  • Malatjalian D., Ross J., Colwell S., Eastwood B. Methotrexate hepatotoxicity in psoriatic patients submitted to long‐term therapy. Can J Gastroenterol 1996; 10: 369–75
  • Zachariae H., Grunnet E., Smgaard H. Liver biopsy in methotrexate‐treated patients: A re‐evaluation. Acta Derm Venereol (Stockh) 1975; 55: 291–6
  • Zachariae H., Sogaard H. Methotrexate‐induced liver cirrhosis: A follow‐up. Dermatologica 1987; 75: 178–82
  • Roenigk H. H., Jr., Auerbach R., Maibach H., et al. Methotrexate in psoriasis: Consensus conference. J Am Acad Dermatol 1998; 38: 478–85
  • Thomas J. A., Aithal G. P. Monitoring liver function during methotrexate therapy for psoriasis: Are routine biopsies really necessary?. Am J Clin Dermatol 2005; 6: 357–63
  • Methotrexate Sodium PDR information. 2004, Mylan Pharmaceuticals Inc., Morgantown, WV 26505. Micromedex
  • Maier H., Honigsmann H. Concentration of etretinate in plasma and subcutaneous fat after long‐term acitretin. Lancet 1996; 348: 1107
  • Beyeler C., Reichen J., Thomann S. R., Lauterburg B. H., Gerber N. J. Quantitative liver function in patients with rheumatoid arthritis treated with low‐dose methotrexate: A longitudinal study. Br J Rheumatol 1997; 36: 338–44
  • Campbell R. M., DiGiovanna J. J. Skin cancer chemoprevention with systemic retinoids: An adjunct in the management of selected high risk patients. Dermatol Ther 2006; 19: 306–14
  • Miller D. W., Feldman S. R. Cost‐effectiveness of moderate‐to‐severe psoriasis treatment. Expert Opin Pharmacother 2006; 7: 158–67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.